SPECTRAL AI, INC. (MDAIW) Reports the reporting period Financial Results
SPECTRAL AI, INC. (MDAIW) announced its financial results for the period ending the reporting period.
Key Financial Highlights:
Revenue: (133
Net Income: $13,980
EPS: Not disclosed
Cash and equivalents: 13980
7 million of advanced funding from the Biomedical Advanced Research and Development Authority (“BARDA”) to accelerate and support additional development and procurement for the DeepView System. ●Following the receipt of FDA clearance for the DeepView System, drew $
5 million under our existing credit facility with Avenue Capital Group, providing non
dilutive capital to further strengthen the Company’s balance sheet. ●Expanded leadership team in advance of commercial activities, including the appointments of David McGuire as Chief Financial Officer and Darcy Bajko as Chief Commercial Officer. ●Completed all remaining milestones under our Department of Defense contract for the DeepView System handheld device, contracted through the Medical Technology Enterprise Consortium (“MTEC”), including the delivery of a fully functioning prototype device. ●Commenced label expansion of the DeepView System to include heads, hands and feet through an extended study based in the United Kingdom. Anticipated Operational and Commercial Milestones ●Generate first
📋 SPECTRAL AI, INC. (MDAIW) - Financial Results
Filing Date: 2026-08-12
Accepted: 2026-08-12 16:03:02
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: